Tactile Systems Technology, Inc. (TCMD) fair value analysis

Nasdaq · Updated 2026-09-07

Tactile Systems Technology, Inc. is a medical device company that develops and markets pneumatic compression devices used to treat lymphedema, venous insufficiency, and other circulatory conditions. The company operates primarily in the United States and serves patients through healthcare providers and clinics.

Forward Fair Value verdict

Overvalued

Based on TickrTrends' weekly Forward Fair Value model, TCMD is trading at a 10–25% premium to estimated fair value.

TCMD currently ranks #94 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Overvalued for 3 consecutive weekly runs.

Last price: $29.78
Sector: Healthcare
12-month range: $13.83–$30.65

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: D
Leverage: Low
RSI zone: Oversold
50/200-day trend: Uptrend
52-week position: The top quarter of its range

What our data shows for TCMD

Our model validated 13 trailing price-to-earnings windows for TCMD, built from quarterly earnings records.
Shares are trading in the upper third of their 12-month price range of $13.83–$30.65.
The 14-day relative strength index sits at an oversold 19.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for TCMD
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent TCMD news

TickrTrends' derived news-sentiment signal for TCMD is currently mixed, computed from recent coverage.

Tactile Systems Technology, Inc. Q2 2026 Earnings Call Summary (finance.yahoo.com, 2026-08-11)
TickrTrends take: Tactile Systems Technology operates in the Healthcare sector where TickrTrends currently rates it as overvalued based on its derived valuation analysis. For investors monitoring the company's valuation relative to its fundamentals, the Q2 2026 earnings call will provide an opportunity to assess whether recent operational performance justifies the current market pricing or reinforces concerns about valuation disconnect. Valuation-focused readers should pay particular attention to revenue trends, margin performance, and management guidance to determine if the company's financial trajectory supports a higher valuation multiple or suggests current pricing may be unsustainable.

What people are saying

Follow the TCMD conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — TickrTrends' derived indicators for TCMD show that the Relative Strength Index moved from the neutral zone into oversold territory this week. The stock maintains an overvalued current valuation verdict based on TickrTrends' analysis. The oversold RSI reading suggests the stock has experienced downward momentum recently.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is TCMD stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), TCMD is trading at a 10–25% premium to estimated fair value and screens as overvalued. The exact fair value and discount are available to subscribers.

What is TCMD's TickrTrends verdict?

TCMD's current verdict is Overvalued, refreshed with every weekly Forward Fair Value run.

How does TCMD compare to other Healthcare stocks?

TCMD ranks #94 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is TCMD overbought or oversold?

TCMD's 14-day RSI is in the oversold zone on TickrTrends' latest weekly data.

All Healthcare fair-value coverage →

Head-to-head comparisons

TCMD vs CAH · TCMD vs CNC · TCMD vs CRL · TCMD vs CVS · TCMD vs ILMN